Humam Kadara

UT MD Anderson Cancer Center

NIH Rank #4490
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career

NIH Funding · FY2024

Total Funding
$2.2M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#4,490
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.2M across 4 grants · National rank #4490.

Top grants by award amount

Humam Kadara's NIH grant portfolio, ranked by award amount.

  • 1R01CA287734-01A1R01
    Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapy
    $670.4K
    award amount
  • 5R01CA272863-03R01
    Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancer
    $593.1K
    award amount
  • 5R01CA248731-04R01
    Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer
    $532.6K
    award amount
  • 5U01CA264583-03U01
    Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
    $411.2K
    award amount

Affiliation

Institutions that have administered grants for Humam Kadara.

Affiliated with UT MD Anderson Cancer Center (TX).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4490
  6. 2024
    Entered Top 25% Nationally
    Ranked #4490